PhotoPharmics Investigating Efficacy of Phototherapy for Parkinson’s Disease
PhotoPharmics, Inc. is currently conducting a pivotal study to demonstrate the safety and efficacy of specialized phototherapy for the treatment of  Parkinson’s disease (PD). Accumulating evidence shows that the eyes are involved in the development of Parkinson’s disease, since PD patients have damaged retinal dopamine neurons. Recent discoveries…